transatlantic, trilateral and multilateral policy cooperation for drug safety
The recultion of drug safety and the governance of globalization in the pharmaceutical industry present growing challenges for govermments, the viotechnology sector and civil society. Currently, regulation and policy is driven by the interests of industrialized nations. However recent conflicts over patents, generics, and emerging ...